Cardiac Amyloidosis: A Practical Overview

presented by American Society of Nuclear Cardiology

1 other would like to attend.

I need an invite

Notification icon Friday, April 12, 2019 7:30 AM - 11:30 AM EST

Location Icon Innisbrook Golf and Spa and Resort, 36750 US Hwy 19, Palm Harbor, FL 34684

Event info

Register HERE!

This half-day CME case-based program explores the diagnosis and management of cardiac amyloidosis. After an overview of the biological basis of cardiac amyloidosis, an interactive case-based panel discussion will address the challenges of disease presentation, the role of various imaging modalities in the diagnosis, including a detailed discussion of technetium-99m pyrophosphate imaging and an overview of current and emerging treatments for transthyretin cardiac amyloidosis. The availability of new treatments has enhanced the importance of a heightened awareness, early diagnosis, and accurate typing of cardiac amyloidosis.

Learning Objectives
At the end of this course, participants will be able to:

  • Describe amyloidosis, including specific types, cardiac features, and disease burden
  • Identify barriers to patient identification and diagnosis
  • Summarize the diagnostic evaluation for CA, including the differential diagnosis
  • Provide details of Tc-99m PYP, including imaging protocol, semi-quantitative, and quantitative scoring, interpretation, and components of an appropriate report 
  • Demonstrate understanding of current and emerging treatments for patients with ATTR-CM

Target Audience:
Nuclear cardiologists, nuclear medicine physicians, multimodality imagers, radiologists, and imaging technologists

The American Society of Nuclear Cardiology designates this live activity for a maximum of *3.5 AMA PRA Category 1 Credits™. 

1 other would like to attend.

I need an invite

Login to view comments. Click here to Login